Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

导出原文传递

翻译打印收藏纠错

作者： Martinez Climent-JA ^[1] ; Comes AM ; Vizcarra E ; Benet I ; Arbona C ; Prosper F ; Solano C ; Garcia Clavel-B ; Marugan I ; Lluch A ; Garcia Conde-J

作者单位： Department of Hematology and Medical Oncology, Hospital Clinico Universitario, University of Valencia, Spain. ^[1]

关键词 Antineoplastic Agents Combined Breast Neoplasms Chromosome Aberrations 抗肿瘤药多剂联用乳腺肿瘤染色体畸变造血干细胞移植白血病骨髓增生异常综合征

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Bone marrow transplantation

2000年25卷11期

1203-1208页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

Bone marrow transplantation

相似文献

Bone marrow transplantation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

Bone marrow transplantation

相似文献

Bone marrow transplantation

相关期刊

检索历史清除